Results 171 to 180 of about 798,278 (191)

Rapid and sustained improvements in Generalized Pustular Psoriasis Physician Global Assessment scores with spesolimab for treatment of generalized pustular psoriasis flares in the randomized, placebo-controlled Effisayil 1 study

Journal of the American Academy of Dermatology, 2023
Milan Anadkat
exaly  

Comorbidities in patients with generalized pustular psoriasis: a nationwide population-based register study

Journal of the American Academy of Dermatology, 2023
Sofia Löfvendahl, Marcus Schmitt-Egenolf   +1 more
exaly  

Generalized Pustular Psoriasis

International Journal of Dermatology, 1987
openaire   +2 more sources

Economic burden of generalized pustular psoriasis and palmoplantar pustulosis in the United States

Current Medical Research and Opinion, 2021
Maya Hanna
exaly  

Trial of Spesolimab for Generalized Pustular Psoriasis

New England Journal of Medicine, 2021
Milan Anadkat, Hervé Bachelez, Siew Eng Choon   +2 more
exaly  

Treatments and outcomes of generalized pustular psoriasis: A cohort of 1516 patients in a nationwide inpatient database in Japan

Journal of the American Academy of Dermatology, 2022
Kiyohide Fushimi, Hiroyuki Matsue, Hideo Yasunaga   +2 more
exaly  

GENERALIZED PUSTULAR PSORIASIS.

British Journal of Dermatology, 1959
openaire   +2 more sources

Clinical analysis of generalized pustular psoriasis in Chinese patients: A retrospective study of 110 patients

Journal of Dermatology, 2021
Ning Yu, Wenjuan Chen, Na Liu
exaly  

Spesolimab, an interleukin-36 receptor monoclonal antibody, for the treatment of generalized pustular psoriasis

Expert Review of Clinical Immunology, 2023
David Burden
exaly  

Successful treatment of paediatric generalized pustular psoriasis with secukinumab: a case series

Journal of Dermatological Treatment, 2022
Kin Fon Leong, Henrietta Albela
exaly